Search
for
Sort by
Research 30 of 1000+
- Serious Adverse effects From Compounding Errors With Low-Dose Oral Minoxidil for Alopecia Treatment
- Compounding as a Current Therapeutic Option in Dermatology
- Using risk analysis to guide changes to compounding formulae
- 5α‐reductase inhibitors: Evaluation of their potential confounding effect on GC‐C‐IRMS doping analysis
- Lasers, lights, and compounds for hair loss in aesthetics
- Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?
- Predicting hair cortisol levels with hair pigmentation genes: a possible hair pigmentation bias
- Evaluating statistics in clinical trials: Making the unintelligible intelligible
- Association of Hair Loss With Suicidality and Psychological Adverse Events vs Finasteride Use—Reply
- Scientific Opinion on the substantiation of a health claim related to iron and maintenance of normal hair growth pursuant to Article 13(5) of Regulation (EC) No 1924/2006
- Topical use of systemic drugs in dermatology: A comprehensive review
- Stability of minoxidil in Espumil foam base.
- COMPOUNDED AND MANUFACTURED MEDICINES: A COMPARATIVE ANALYSIS OF EFFICACY, SAFETY, AND ACCESSIBILITY IN PHARMACEUTICAL CARE
- Survey of the Prices of Topical Compounded Medications for Alopecia in the Tri-State Area.
- Drugs and Hair Loss
- Compatibility of Caffeine Clobetasol Propionate Dutasteride Nicotinamide and Progesterone in TrichoFoam™, a Natural Vehicle for Hair Foams.
- The forensic limits of hair drug testing: a critical assessment of drug intake and hair concentration relationships
- ESTUDO DE PRÉ-FORMULAÇÃO DE SHAMPOO PARA TRATAMENTO DA ALOPECIA ANDROGENÉTICA CONTENDO CAFEÍNA COMO ATIVO
- Biopharmaceutical Performance of DiluCap: A Line of Functional Excipients Enhancing Dissolution Profiles of Minoxidil, Finasteride, Melatonin, and Naltrexone.
- Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair Solutions.
- Compatibility of Different Formulations in TrichoConceptTM Vehicles for Hair Treatments
- Pre-formulation study of shampoo for treatment of androgenetic alopecia containing caffeine as active ingredient
- Do follicles matter? Testing the effect of follicles on hair cortisol levels
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
- PS6:125 Systemic lupus erythematosus diagnosis is earlier in males compared to females
- A Bidirectional Mendelian Randomization Study of Androgenetic Alopecia and Obesity
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Comment on “A Cross-sectional Observational Study to Correlate the Trichoscopic Findings of Female Pattern Hair Loss with the Disease Severity and Underlying Histopathological Changes”
- Re: The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA): A population‐based case–control study